Blis Technologies reports revenue and earnings growth for FY25

BLIS Technologies (NZX:BLT) announced positive financial results for FY25, driven by strategic execution and operational momentum. Revenue reached $12.6m, a 10% increase year-over-year, supported by strong finished product sales. EBITDA improved by 26% to $1.0m, exceeding guidance. Net Profit also rose to $0.8m, surpassing the previous year's $0.6m. The company addressed unexpected intellectual property issues during the year and is currently working with its largest European customer to resolve a dispute regarding patent filings. BLIS is focused on delivering revenue growth through key B2B partnerships and leveraging existing B2C markets. A significant China regulatory approvals project was largely completed, with the company awaiting the regulator's review. Looking ahead, BLIS enters FY26 with cautious optimism, aiming to prioritize revenue growth and innovate in oral health.